A phase I biological study of azacitidine (VidazaTM) to determine the optimal dose to inhibit DNA methylation

Title
A phase I biological study of azacitidine (VidazaTM) to determine the optimal dose to inhibit DNA methylation
Authors
Keywords
-
Journal
Epigenetics
Volume 5, Issue 8, Pages 750-757
Publisher
Informa UK Limited
Online
2010-11-30
DOI
10.4161/epi.5.8.13105

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started